Vitamin Shoppe Inc(NYSE:VSI) announced the earnings results for Fiscal Year 2016 and Q2. The results came in during Pre-market on Aug 3, 2016. Company reported revenue of $332.72M. Analysts estimated a revenue of $331.58M. Earnings per share were $0.55. Analysts had estimated an EPS of $0.59.
Vitamin Shoppe Inc (VSI) made into the market gainers list on Fridays trading session with the shares advancing 0.49% or 0.13 points. Due to strong positive momentum, the stock ended at $26.85, which is also near the day’s high of $26.93. The stock began the session at $26.76 and the volume stood at 1,56,908 shares. The 52-week high of the shares is $37.31 and the 52 week low is $26.02. The company has a current market capitalization of $644 M and it has 2,40,00,924 shares in outstanding.
Several Insider Transactions has been reported to the SEC. On Jun 1, 2016, Guillermo Marmol (director) purchased 1,000 shares at $30.23 per share price.Also, On Aug 18, 2015, B. Michael Becker (director) sold 845 shares at $36.74 per share price.On May 26, 2015, Colin Frederick Watts (CEO) purchased 2,400 shares at $41.02 per share price, according to the Form-4 filing with the securities and exchange commission.
Vitamin Shoppe Inc. (VSI) is a multi-channel specialty retailer and contract manufacturer of vitamins minerals herbs specialty supplements sports nutrition and other health and wellness products (VMS). The Company operates through three segments: retail which includes Vitamin Shoppe Super Supplements and Vitapath retail store formats; direct which consists of its e-commerce and catalog formats and manufacturing which consists of the Nutri-Force manufacturing operations. The Company operates through its wholly owned subsidiary Vitamin Shoppe Industries Inc. and Vitamin Shoppe Industries Inc.s’ wholly owned subsidiaries VS Direct Inc. Vitamin Shoppe Mariner Inc. (VSM) VS Hercules LLC (VSH) Vitamin Shoppe Global Inc. (VSG) and Vitapath Canada Limited (VCL).